Substitution of Wild‐Type Yellow Fever Asibi Sequences for 17D Vaccine Sequencesin ChimeriVax–Dengue 4 Does Not Enhance Infection ofAedes aegyptiMosquitoes
Open Access
- 1 March 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (5) , 686-692
- https://doi.org/10.1086/527328
Abstract
To address concerns that a flavivirus vaccine/wild-type recombinant virus might have a high mosquito infectivity phenotype, the yellow fever virus (YKeywords
This publication has 37 references indexed in Scilit:
- Yellow Fever: A Disease that Has Yet to be ConqueredAnnual Review of Entomology, 2007
- Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgutJournal of General Virology, 2006
- Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to AllHuman Vaccines, 2006
- Long-Term Transmission of Defective RNA Viruses in Humans and Aedes MosquitoesScience, 2006
- Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoesJournal of General Virology, 2005
- ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and EfficacyJournal of Virology, 2004
- Arguments for live flavivirus vaccinesThe Lancet, 2004
- The extent of homologous recombination in members of the genus FlavivirusJournal of General Virology, 2003
- EMERGING AND RESURGING VECTOR-BORNE DISEASESAnnual Review of Entomology, 1999
- Heterologous resistance to superinfection by louping ill virus persistently infected cell culturesArchiv für die gesamte Virusforschung, 1992